Jeffrey Tyner

School of Medicine, Knight Cancer Institute

Publications

• 1.

  2013

  Erin B. Dickerson; Kevin Marley; Wade Edris; Jeffrey W. Tyner; Vidya Schalk; Valerie MacDonald; Marc Loriaux; Brian J. Druker; Stuart C. Helfand

  Imatinib and dasatinib inhibit hemangiosarcoma and implicate PDGFR-β and Src in tumor growth

  Translational Oncology. 2013;6(2):158-168.

• 2.

  2013

  Kim-Hien T. Dao; Jeffrey W. Tyner

  Next-generation medicine: Combining BCR-ABL and hedgehog-targeted therapies

  Clinical Cancer Research. 2013;19(6):1309-1311.

• 3.

  2013

  Daniel Bottomly; Beth Wilmot; Jeffrey W. Tyner; Christopher A. Eide; Marc M. Loriaux; Brian J. Druker; Shannon K. McWeeney

  HitWalker: Variant prioritization for personalized functional cancer genomics

  Bioinformatics. 2013;29(4):509-510.

Journals

•  
  Publications
• Blood
  9
• Leukemia
  6
• Cancer Cell
  3
• Cancer Research
  3
• Cell Cycle
  2

Institutional Network

• Internal Organizations
  Shared Pub.
• Pathology
  23

  
• Hematology & Medical Oncology
  14

  
• Pediatrics
  5

  
• Academic Graduate & Interdisciplinary Program
  1

  
• Biochemistry & Molecular Biology
  1

  
• Clinical & Translational Research
  1

  

• External Organizations
  Shared Pub.
• Howard Hughes Medical Institute
  10
• Washington University in St. Louis School of Medicine
  9
• Harvard Medical School
  4
• Cell Signaling Technology, Inc.
  3
• The Johns Hopkins School of Medicine
  2
• OHSU School of Medicine
  2

Coauthor Network

• Internal Coauthors
  Shared Pub.
• Brian Druker
  25

  
• Marc Loriaux
  22

  
• Michael Heinrich
  9

  
• Bill Chang
  5

  
• Tibor Kovacsovics
  3

  
• Carol Beadling
  2

  

• External Coauthors
  Shared Pub.
• Michael J Holtzman
  8
• Thomas Ohare
  7
• Edy Y Kim
  5
• Anand C Patel
  4
• D Gary Gilliland
  4
• Christopher A Eide
  3